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EXECUTIVE SUMMARY 
Renewable feedstocks derived from agricultural or forest products o t k r  a potential alternative to fossil 
feedstocks for the production UT chemicals. Initial efforts to establish t h ~ s  new technology of’tcn focus on 
developing processes that convert glucose derived from corn wet milling into the desired productc. 
However, the use less expensive, more complex fecdstocks derived from other biological materials could 
provide significant improvements in the economics of a prccss, making them more competitive with 
existing petrnchcmical processes. The use of lignocellulosic hydrolyzates could decrease fedstock sugar 
costs by 50-70% compared to corn glucose. 
Our goal was to m d f y  or develop microbial strains capable of suwinate production h m  xylose and to 
test the utility of this new modified microbes for production of organic acid {e.g., succinic acid) from 
industrial lignocellulosic hydrolyzates as well as to improve on the prior bio-based succinic acid prwess. 
The approach was to develop ar~ improved xylose-metabolizing E. coli mutant and to test the expression 
of utility of this new modified microbes for production of organic acid (e.g., succinic acid) from industrial 
lignocellulosic hydrolyxates. The team would also improve on the prior bio-based succinic acid process 
by focusing on the critical high cost steps in separation. 
ORNL tcsked the base case strain (ATCC ATCC 202021; US Pat pt 5770435) and subsequent derived 
strains for xylose metabolism and for fermentation of mixed sugars and actual hydmlyzates. Arkenol 
probided compositions and actual lignoccllulosic hydrolysates. ANL worked on strain development, 
modification. isolation and identificatim of critical mutations. The E.coli, ATCC 20202 1 ,  was not 
capahlc o r  xylose metabolism, but a subsequent mutant was, eliminating the need to genetically engineer 
insertlon o f  xylosc genes. Another better xylose metabolizing mutant was isolated (E. coli, AFP 184, 
patent pending). This was also tcstcd on actual lignocellulosic hydrolyzates; Arkenol, hc., provided rice 
straw hydrolysate as a representative feedstock. We also dctermined the critical genes (e.g., pfsG) for the 
cnhanced succinate production. 
RCC worked on economics, new markets developments, scale-up and improvement o f  the separations. 
ACC reduced the prwcess costs hy modification of the separation process from membranes to 
crystallization reducing the separations cost by over half. ACC has shown other markets for deicers, ester 
solvents, and succinic acid itself. Economic estimates showed this prncess to he competitive with 
petrochemical-based production of the same products and that hydroljzates would further decrease the 
cost. ACC has recently completed a fkrmcntation dewnstration run at 150.0001, using glucose. 
Key technical achievements were: 
Production of succinic acid rrom Libmacellulosics {mixed xylose and glucose) 
- All AFP three strains can produce SA from xylosdglucose mixtures 
9 
AFP 184 i s  best in yield and concentrstion Cpatcnt pmd.) 
ptsC mutant is key in shift to good SA production 
A11 convert actual Arkcnol hydrolyzates w/o inhibition 
Xylose fermentation is linked to glucose conversion - 
Investigation of the use of spent medium for cell growth and succinic acid production 
A K  Separations hy improved crystallization to eliminate high energy membrane step 
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INTRODUCTION GVD PURPOSE 
The purpose of this Cooperative Rcscarch and Development Agreement (CRADR) between UT-Battelle, 
LLC (LTB) and Argonne National Laboratory (ANL), (collectively referred to as the "Contractors"), and 
Applied CarboChemicals, Inc. (Participant), i s  to add and test new metabolic activities to existing 
microbial caialysts for the production of succinic acid from renewables. In particular, we seek to add to 
the existing organism the ability to utilize xylose efficiently and simultaneausly with glucosc in mixtures 
of sugars or to add succinic acid production tu another strain and to test the value of this new capability 
fur production of succinic acid from industrial lignocellulosic hydrolysates. The Contractors and 
Participant are hereinafter jointly referred to as the "Parties." 
Research to date in succinic acid fermentation, separation and genetic engineering has resulted in a 
potentially economical process based on thc use of an Escherichia coli strain AFPl 11 with suitable 
characteristics for the production of succinic acid from glucose. Econumic analysis has shown that higher 
value commodity chcrnicals can be economically prduced from succinic acid based on preliminary 
laboratory findings and predicted catalytic parameters. The intid target markets include succinic acid 
itself, succinate salts, esters and other derivatives for use as deicers, solvents and aciddants. The other 
commodity products from the succinic acid platform include 1,4-butanediol, y-butyrobdctone, 2- 
pyrrolidinone and N-methyl pyrrolidinone. Current economic analyses indicate that this platform is 
competitive with existing petrochemical routes, especially for the succinic acid and derivatives. 
This research builds on a previous C M D A  project which included thc Parties. The gual of the earlier 
CKADA project (OWL 96-0407) was to develop and demonstrate from bench results an cconornically 
promising and competitive process for the production of chemical derivatives from biologically produced 
succinic acid. AFPI 11, a new strain dscoverd at ANL, has bccn scaled to 500-L scale using a process 
developcd at the Oak Ridge National Laboratory (OKNL) with cnrn glucose a the feedstock. The key 
need here is to furthcr lower the costs by the utilization of a cheaper feedstock (lignocellulosics from 
renewables or wastes). 
The rcpori will present the planned CRADA objectives followed by the results. Thc rcsults section has a 
combined hiocstalysis and fermentation section and a commercialization section. This is B nonproprietary 
report additional proprietary information may be d e  available subject to acceptance of the appropriate 
proprietary information agreements. 
TECHNICAL OBJECTIVES 
The overall goal of the CRADA is to develop and test the feasibility n fa  m d i f i c d  microbe for production 
of succinic acid from both hexose and pentose sugars (e.g., glucose and xylose, respectively). We will 
improve the formation of succinic acid h m  mixtures of sugars by strain AFPl 11 and its variants through 
optimization of fermentation conhtions and genetic cngineering of rate-limiting genes. The initial focus 
will be on metabolism of xylose and arabinose, including the possible limilalion to uptake and 
metabolism, then on cellobiose utilization. Ths goal is to be met by obtaining the follnwing key 
objectives : 
1. Metabolic engineering: la) Re-expression of' gene(s) in E.coli AFP1 1 1 most need to be amplified to 
improvc co-utiliza tion uf pentoses. 1 b) Development of similar succinate mutant fmm robust xylose 
fermenter. 
2. Fermentation: 2a) Evaluation nfthc existing strain, AFPll1 and its known variants for fermentation of' 
xylose and mixed sugars in fed-batch process. 2b) Evaluation o r  hmentation and succinic acid 
production of new variants. 2c) Testing of actual industrial lignocellulosic hydrolysates on the best 
available microbes. 
3. Economic and market analysis of thc process nith process improvements. 
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The original CRADA tasks and milestone are shown in the appendix. As seen in the results, all rnajclr 
objectives were met; however some t a k s  did change during the course of the project. 
ANL led thc cfforts on strain development. ORNL led the fermentation efforts. Davison (ORNL) was the 
overall project lead. ACC worked on the market development and process scalc-up and 
commercialization. We had conferencc calls involving the principal investigators from ANL, O W L ,  and 
ACC. ACC provided economic and marketing asscssmcnts. ACC utilized a subcontractors and 
stratcgic partner to perform some process development and scale-up. Another strategic partner assisted in 
the process economics. Arkenol, Inc was a nonsignatmy partner to this research. They providud in-kind 
suppon of actual lignmcllulosic hydrolyzates and the compositional analysis. 
ORNL is managed now by UT-Batelle, LLU; it was managed by Lockheed Martin Energy Research when 
the CRADA was signed. As of May 2003, Applied Carbnchemicals, Tnc. has changed its name to 
Diversified Natura! Products. 
CRADA RESULTS 
Biocatal ysis Developrncn t (Metabolic Engineering and Permen tation) 
Summary 
The objective of the C W A  “Productinn nf succinic acid from lignocellulosic hydrolysates” was to 
cstablish a proprietary strain for the efficient production of succinic acid from incxpmive agriculturdl 
feedstocks. lnitial ruscarch hcused on engineering E. cdi  strain AFPlll, developed under an earlier 
CRADA for the production of succinic acid from glucose, to allow metabolism of the mixtures of sugars 
found in lignocellulosic hydrolysates. An actual hydrolysate was provided by Arkend, Inc, to allow real- 
world evaluation of the strain’s performance. Gvaluation crf AFPl 1 1  showed it was unable to metabolize 
xylose, the major pentuse sugar found in lignocellulosic hydrolysates. A mutant of AFPl 1 1, called 
AFPXI, was obtained that had rcgained h e  ability to metabolize xylose. This strain was able to convert 
the mixed sugars in the Arkenol hydrolysate to succinic acid, but only at moderate rates. 
Later work, initiated in response to the desire of Appiied CarboChemicals to evaluate alternative hosts for 
succinate production, transferred the mutations hd allowed succinic acid production in AFPl 1 1 into a 
different lineage of E. coli selected for its vignrnus growth. In l h i s  case, the parental strain already 
rnctabolized xylose. Introduction of the mutations generated a strain, AFPl X4, that produced succinic acid 
h m  the Arkenol hydrolysate sibmificantly better than &d AFPX1. The strain produced succinic acid 
efficiently and reproducibly in the fermenter using only indusbial grade medium components containing 
the lignocellulosic hydrolysate as a source of sugars and corn steep liquor, a byproduct of corn wet 
milling as a source ofniimgen and other nutrients. 
Finally, new strains were constructed in both lincagcs using entirely non-reverting, knockout mutations to 
give strains AFP400 and AFP404. A patent application covering thc new strains has been filed. The 
mutant strains were determined to be non-recombinant (not a GMO, genetically modified organism) due 
to the traditinnal methods (nul genetic engjneering) used and thus eliminated a regulatory concern. 
Details 
Renewable fkedstwks dcrivcd rrom abyicultural or forest products offer a potential alternative to fossil 
feedstocks for the production of chemicals. Initial efforts to establish this new technology often focus on 
developing processes that convert glucose derived from corn wet milling into the desired products. 
H o w v c r ,  the use less expensive, more complex feedstocks derived from other biological matcrials could 
provide significant improvemcnts in thc economics of a process, malung them more competitive with 
existing petrochemical processes. In this CRADA, we developed new bacterial strains that can take 
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advantage of the cheaper sugars available In hydrolysates of lignncellulosic material for the prduction of 
succinic acid, a precursor of established building blocks of many commercially used polymers. hrkenol, 
Tnc., provided rice straw hydrolysate as a representative feedstock. Table 1 lists the typical composition of 
rice straw before hydrolysis. 
Table 1 .  Composition of rice straw. 
Feedstock cornnoncnt 
Glucan 
Mannan 
Galactan 
Xylan 
Arabinan 
Lignin 
Extractives 
Ash 
Drv WtYq 
38.9 
0.0 
0.5 
20.4 
3.4 
13.5 
5.3 
18.0 
After hydrolysis and removal of the solid lignin and ash present in the material, the major sugars present 
in the Arkenol hydrolysate are glucose and xylose, in approximately a 2: 1 ratio, with traces of arabinose. 
E. coli normally produces a mixture nf products fiwm glucosc, but strain AFPl11, created by addition of 
three mutations into strain W1485, converts glucose eficiently to succimc acid (Fig. 1). Two of the 
mutations block the enzymes that normally produce formate and lactate. The third mutation, that allows 
succinate furmrltiun, is in the ~ L S G  gene. This gene encudes a protein involved both in the tmnspurt of 
glucose and in the regulatinn metaholistn of mixtures of sugars. It represses the use of other sugars when 
glucose in present. but because it is absent AFPl 1 I should be able to metabolize lignocellulosic 
hydrolysates well. Ilowever, AFP111 was unable to grow on xylose. Literatwe reports indicate that E. 
r d i  strains that have been cultured in the laboratory for many years often lose their ability to metabolize 
xylose, and that in some cases this ability can be regained simply by forcing the strain to grow nn xylose 
exclusively. Plating of AFPl 1 1 on xylose medium resulting in spontaneous revertants that were able to 
grow efficiently on xylose. Several of these were purified and characterized more extensively. All were 
fuund to metabolize xyiose similarly, and one, designated AFPX1, was studied further. It was shown to 
convert bnth the xylose and glucose present in rice straw hydrolysates (Fig. 2). 
Figure 1. Metabolism of glucose by W 1485 and AFP I 1 1. 
W1485 AFPl 1 1 
Glucose 
Ethanol 
Glucose a 
PEP @ a  
Succinate 
QAcetate 
Ethenol 
6 
Figure 2. Metabolism of a rice straw hydrolysate by AFPX 1. 
Succinic Acid Production from Rice Straw 
Hydrolysate by AFP X1 
60 I 
40 - 
30 
20 
10 
0 
-4- Gkrcose 
+ Xylose 
7t Succinate 
-t Acetate 
0 20 40 60 80 
Fermentation Time (h) 
AFPXl fulfilled a major objective of the CRADA, generation of a derivative of AFPI 1 1  that could 
convert hydrolysates to succinic acid. However, the rate of succinate formation was slow. In the second 
year, rather than optimize AFPXl, where the characteristics of the final strain would be limited to some 
extcnt by the genetic background of the W1485 lineage, we introduced succinic acid production into a 
different lincagc oIE.  coli that had better growth characteristics. The decision tn do this was bawd in part 
on the desire, expressed by Applicd Carbochemicals, to evaluate alternative, more robust hosts. A wld  
type strain was obtained from the culture colluction or Dr. Edward St.Martin of Argonne National 
Laboratory. This strain was known to grow very wgorously, and had not been culiured extensively in the 
laboratory (avoiding the debilitation that can occur when strains are cultured extensively on rich mcdia, 
such as the loss of the ability to grow on xylose that had occurred in the W1485 lineage). Strain AFPI X4 
was developed by sequentially introducing the threc mutations required for succinic acid production into 
this ~ i l d  type strain strain (Fig. 3). 
AFP 184 converted the sugars present in the rice straw hydrolysate to succinic acid rapidly and generated 
high final concentrations of succinic acid (Fig. 4). The jumps in the concenkation of glucose and xylose 
in this figure reflect additions of more hydrolysate. 'The rate of  formation of succinalt: by AFPlS4 was 
significantly highcr lhan that observed for AFPXl (compare Figs. 2 and 4). In the initial 24 hours of thc 
production perid (starting 6 hours into h e  experiment), AFP184 made succinic acid at a rate of 1.22 
@Lh compared to 0.7 g;Lh for M P X 1 .  Experiments using purified glucose as substrate substantiated this 
ditlkrcncc belween the stmins (Table 2). In addition, the final concentration obtained was also 
significantly higher. Tho yicld of succinic acid based on glucose was comparable for the two strains. The 
improved productivity and titer obtained hy AFP184 could improve the economics of a process for 
production of succinic acid, 
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Tahle 2. Mclrics for the production of succinic acid h m  glucose in test tube. 
Strain SA Titcr (dL1 Productivitv (p;iLh) Yield ldg g Iucosel 
AFPl 11  51 0.87 0.95 
AFP 1 84 72 1 .oo 0.91 
AFP184 possessed additional attributes that could contribute to an industrial scale process to make 
succinic acid. Because of its vigorous growth, smaller inoculum cultures were neodt4 thc dilute initial 
culture quickly grew to high density prior to the production phase. AFf184 also remained healthier much 
further into the production cycle than AFPl 1 I ,  as indicated by the ability to use a production phase 
culture to inoculate a second production cycle. I n  contrast, secondary cultures of AFPl I 1  performed 
poorly. This latter trait could allow development of a continuous or semicontinuous process frir succinic 
acid production using AFPl X4. Othur metrics for AFP 184 are in Table 3. 
Table 3. Metric for production of succinic acid from glucose and from hydrolysate in 1-L 
fermentation at 72h. 
Glucwe as carbon source AFPl I f  AFP 184 
Yield (g SNg G consumed) O.67 1.04 
Hydrolysate as carbon source 
Yield ( g  S A / g  CitX consumed) 0.58 1.13 
SA Tiler ($L) 36 4s 
SA titer (g/L) 30 49 
Figure 3. Constnictim of AFP184 from a wild type E. coli strain. 
Wild type (prototrophic, vigorous growth) 
1 
Wild type (ptsG21, &JlB::Cam) 
Wild type @tsG2I, ApflB::Cam, dr n r n::Kan) 
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Fig. 4. Conversion of rice straw hydrolysate to succinic acid by AFP 184. 
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Two additional strains were also developed in the course of the CRADA research. The original mutation 
in the pIsC gene of AFPl l1 ,  AFPXl and AFP1.34 was a point mutation. As such, it  is possible that a 
secondary mutation could restore a functional PTSG protein, eliminating succinic acid production. To 
insurc that this could not occur, we constructed a knockout of the ptsG gene by cloning the utiniodificd 
gene and inserting an antibiotic resistance gene into the p s G  gme (eliminating the possibility of 
reversion). The modified gene was intrurluced into the lineage of both W 14x5 and thc wild type strain by 
a method that replaced the native gene, gcnerating non-revertable mutations of pt.G. The resulting 
strains, AFPMQ and AFP404 (Table 41, contain three nnn-reverting knockout mutations that, in concert, 
allow succinic acid production born mixtures of sugars. These strains fcrmented glucose to succinic acid 
similarly to their relatives, AFPl 1 1 and AFP 184, respectively. 
Table 4. Triplc knockout mutants for production of succinic acid. 
Strain Hosl Phenotype 
AFP4OO W 1485 Jpf7t::Cain: IdhA::Tet,ptsG::Ran 
AFP404 wild type I IpjlB::Cam, Id&::Tet,ptsG::Kan 
The final strain, AFP404, reprments thc best strain developed under the CRADA arid i s  recommended for 
futurc process optimization. 
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Commericaliza tion (ACQ 
There arc thrct: primary aspects to Applied Carbochemicals, lnc. commercialization efforts: process scale- 
up, economics, and marketing of new product applications. 
The DOL‘ACC fermentation prilcess route provides an opportunity to mrtnufacture an array ofsuccinate 
salts, such as sodium. potassium or ainnioniurn succinate, depending on the neutralization strategy 
chosen. These salts have large volume merchant applications that the company is currently exploiting. 
Product and markct development efforts involve the testing of these succinate salts in target applications 
against existing c heinicals to cstablivh pricelpaformance analysis. Additionally, customer evaluations 
provide the specifications of the end prducts which are back integrated into the process developnient 
efforts lo ensure that the process flows are consistent with consumer demands and cash cost analysis for 
these end-products can be assessed before commencing the negotiation of the  em and conditions of 
supply contracts. The company’s short-tcm commercialization strategy focuses on the introduction of 
ruccinate salts to high growth core markets, whrrc thc price and performance of these salts offer the 
company sustainable competitive advantages. Process, product and market development efforts will 
continue to support the initial launch of these products. 
Process Scde L@ 
Fermentation: Michigan Biotechnology Institute (MBI) in East Tmsing, MI, wurked with ACC to refine 
the process conditions and scale the process up to the 3700 liter scale. This scale up yielded valuable 
information that enabled the devclopment u f  the final Standard Operating Prwcedures enabling us to 
engage a contract fermentation house for the final scale up and eventual contract manufacturing. The 
tinal scale at ME1 (3700 liters) would be the volume of the innoculum tank fur our commercial scale up, 
which was cilnducted by F d r o  Manufacturing LP in ICmgstree, SC. The FermPro run was conducted 
at a 150,000 liter scale. 
Separations: The separations work was originally carried oul at MSU. The separations work is now 
being cnnducted under a Phase 2 SI3LR through LecTec, in Lansing, MJ. ACC has an ownership position 
in LecTec, which i s  nnw functioning as the technology development arm of AUC. Current work i s  
concentrating on finalizing the coupling of the r~entatio~’separations operations for a smooth transition 
to thc various downstream synthesis operations. Crystallixation has replaced membrane electrodialysis as 
the prefcrrcd separation scheme. However, several product lines h a w  been develuped for the partially 
purified salt form. 
Prucess Economics 
Frocess Econoinics were developed by O W ,  ProForma Systems, Raphael Kat7.n Associates 
International (Katzen), Inc. and AUC. K a k n  rontlered the original opinion on the viability of the 
economics based on data supplied by ProFornia, OKNL and ACC and discussions with ACC personnel. 
Subsequent economic rcfinements of downstream processing and the incorporation o f  ncw, proprietary 
separation operations were cotiductcd by ProForma Systems and ACC. ACC proprietary improvements 
and patents in separations, formulation, fernientation, and catalysis lower the project SA cost well below 
target of40 .2Ylb SA 
Marketinflarket Dmelopm eM 
Activities in Marketing arid Markct nevelupment have been largely orchestrated by ACC in collaboration 
with numerous industry partners in the various markets and applications identified by ACC as target 
markets. AOC has availd itself of niulticlient studies as wcll as the expertise of those already in the 
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markctplacc. Marketing efforts have been conducted on a global basis, and ACC is working with 
companies all over the world. Figurc 5 demonstrates the breadth of the product offding and market 
applications that are enabled by the succinic acid platform. In particular, R&D and tests shuuld that 
succinate salts act as a improved, biodegradable, very low con+osion deicer. 
Range & Application Novel Reaction Pathways 
/ \  
I 
Succinic Auhjdride 
Figurc 5. Succinic Acid as a Platform Molecule 
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APPENDIX 
SUBJECT PATENTS AND INVENTION DISCLOSURES. 
Subject patents and invcntinn disclosures developed under CRADA: 
Method for Construction of Bacterial Strains with Increased Succinic Acid Production, 
6,159,738. 12:12iOO M. Donnelly et al. Argonne National Laboratory 
ACC Patents Related to CRADA 
SEPARATION 
Succinic Acid Production and Purification I and T I  
FORMULATION 
Enhanced Herbicides I 
Deicing Compositions and Methods of lJse 
US Patent # and date 
#5,958,744 (9/28/99) & 
#6,265,190 (7/24!0 1) 
#6,218,336 I31 (4/17:01) 
#6,287,480 (9/1 1 i O 1 )  
DOWNSTREAM SYNTHESIS 
Dicarboxylic Alkyl Phosphate Esters of epoxy succinic acid 
There are also ten pending ACC patents for further product and process improvements 
#6,,224,038 (5/8/0 1) 
PREEXISTING INTELLECTUAL PROPERTY 
US Patent # 5,770,435 “A Mutant E. Coli Wain, AFT1 11, with Increased Succinic Acid Production” 
Mark Donnelly, Cynthia Millard, Lucy Stols - Argonne National Lab. 6/23/98. 
Reissued i~ RE 37,303 9/25/01. 
U.S. Patent #5,869,301 A Fermentation Process for the Production of Dicarboxylic Acids. N. P. Ngheim, 
M. Donndly, C. Millard 2/9/99 
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Appendix 
Original CRADA Milestones and Decision Points (August 1999) 
PROJECT Y E W  I 
Fermentation Milestones: 
Eshblish eficiencylimitations of AFPl 1 1 in metabolizing mixed sugars. 
Optimi;.~ fcrmmtation of mixed sugars by AFPll  1 
Report on potential of alternative strains 
Metabolic Engineerhe Milestones 
Initiate cloning of target gends). 
Introduce, express, and measurc effect of gene in AFP 1 1 1 
Economic and market analvsis 
Prepare report on economic and enerby assessment for use in DOE metrics 
Decision Point Milestone: 
Is overexpression of genes for pentose metabolism necessary? 
If yes, continue cloning as guided by results. 
If no, concentrate on cellnbiosc and fermentation optimization 
PRT).IEn YEAR 2 
Fermentation Milestones: 
Milestone: 
Establish effect of cellobiose genes in the fermenter 
Deinonstrate tkrmentation of real hydrolysate by modified M Y 1  1 1 
Metabolic ewineering 
Clone, express and evaluate additional gene(s) of pentose mctahoiism. 
or - Integratc genes of pentose metabolism. 
Select variants with improved metabolism of mixed sugars. 
Economic and market analysis 
Prepare marketing reprt of succinate derivatives 
PROJECT YEAR 3 
Pilot Plant Demonstration 
Running a fermentation at least 500L scale 
6 months 
12 months 
12 months 
h months 
12 months 
9 months 
12 months 
6 months 
1 2 months 
4 months 
12 months 
15 months 
36 months 
As sccn in the results, all major objectives were met; however sotnc tasks did change during the course of 
the project. 
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Appcndix 
Funding Support 
The total estimated cost of this CRADA is $S05,000 (cxcluding the Federal Administrative Charges). 
The Government's estimated contribution, which is provided through the Contractors' contracts with 
DOE. is $255,000, subject to available funding. The Pmicipant's estimated contribution is S25C1,OOO 
(with $50,000 uf that amount being funds-in to one of the Contractors). Since the Participant is a small 
business, DOE has waived thc billing of $1,500 in Federal Administrative Charges, which increases the 
Government's contributinn tn $256,500. The total authorized amount LO be expended on this CRADA by 
the Contractors is $305:000, of which $255,0W is programmatic funds and $SO,oOO is Litnds-in from thc 
Participant. The amount of funds, in thousands of dollars, is summarized below for each project year: 
Parties 
DOE'S 
C'oritributi on ti il 
Contractor (LTR) 
35 
X K ~ E ' s  Contribution 100 
via C'ontractor 
( A N I . )  
Participant 
{ Ill-Kind 
C'ontrihution) 
Tobl 210 
45 
I O  
I70 
0 
0 
125 
0 
I25 
90 
I65 
5135 
Rcscarch performed prior to formal CRADA brought DOE support to $560k was funded FY98-FYOl. 
The funds-in were never providcd to ANL. 
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Final Report Certification 
for CRADA Number 94-0552 
between 
UT-Batelle, LLC 
and 
Argonne National Laboratory 
The following certification i s  made for the subject final report: 
la) The final report contains a claim that information contained in the final report is 
qualifying as “Protected CRADA Infomation” (PCI) and any PCI is identified as 
such in the report; 
or 
lb) neither Energy Research nor the participant asserts any claim to information 
contained in the final report as qualifying as “Protectd CRADA Infomation”; 
3) 
that Energy Rcscarch and the participant have no objection to public distribution 
of the final report due to patentable information; and 
the final report contains no prnprietary information. 
For thc Participant: 
(Namc) 
(Title) 
..- 
(Date j 
Final Report Certification 
for CRADA Number 99-0552 
between 
UT-Batelle, LLC 
and 
Applied Carbochemicals, Inc. 
The following certification is made for the subject final rcport: 
I a) The final report contains a claim that information contained in the final report is 
qualifying as “Protected CRADA Information” (PCI) and any PCI is identified as 
such in the report; 
Ih) neither Encrgy Research nor the participant asserts any claim to information 
contained in the final report as qualifying as “Protected CRADA Information”; 
2) that Energy Research and the p a ~ c i p a n t  have no objection to public distribution 
of the final report due to patentable information; and 
the final repoJz contains no proprietary infonnation. 3) 
For the Participant: 
(Date) 
